CRISPR Therapeutics AG Business Finance Contracts & Agreements

28 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Share Issuance Agreement between CRISPR Therapeutics AG and Holder
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2025
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2025
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2024
Investment Agreement between CRISPR Therapeutics AG and Investors (February 13, 2024)
Investment Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2024
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Underwriting Agreement between CRISPR Therapeutics AG and Underwriters for Sale of Common Shares (June 30, 2020)
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Assignment of Sublease and Sub-Sublease Agreement between Casebia Therapeutics LLC and CRISPR Therapeutics, Inc. (December 13, 2019)
Assignment Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Description of CRISPR Therapeutics AG Common Shares Registered under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2020
CRISPR Therapeutics AG Underwriting Agreement for 4,250,000 Common Shares with Goldman Sachs, Piper Jaffray, and Jefferies
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2019
Open Market Sale Agreement between CRISPR Therapeutics AG and Jefferies LLC (August 30, 2019)
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2019
Underwriting Agreement for Sale of 4,210,526 Common Shares by CRISPR Therapeutics AG to Underwriters (Goldman Sachs, Piper Jaffray, Barclays)
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Open Market Sale Agreement between CRISPR Therapeutics AG and Jefferies LLC (August 31, 2018)
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Restricted Stock Unit Award Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Restricted Stock Unit Award Agreement for Employees under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2018
CRISPR Therapeutics AG Restricted Stock Award Agreement under 2018 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Non-Qualified Stock Option Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Non-Qualified Stock Option Agreement for Employees under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2018
CRISPR Therapeutics AG Underwriting Agreement for 5,000,000 Common Shares with Goldman Sachs, Piper Jaffray, and Barclays
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Restricted Stock Unit Award Agreement for Non-Employee Directors under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
CRISPR Therapeutics AG Restricted Stock Unit Award Agreement for Employees under 2016 Stock Option and Incentive Plan
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2017
CRISPR Therapeutics AG Restricted Stock Award Agreement under 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Non-Qualified Stock Option Agreement for Non-Employee Directors under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Non-Qualified Stock Option Agreement for Employees under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Underwriting Agreement between CRISPR Therapeutics AG and Underwriters (Citigroup, Piper Jaffray, Barclays) for Common Shares Offering
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2016
Crispr Therapeutics AG 2015 Stock Option and Grant Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Registration Rights Agreement among Investors and Crispr Therapeutics AG (June 10, 2016)
Registration Rights Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Subscription Agreement between CRISPR Therapeutics AG and Bayer Global Investments B.V. (December 19, 2015)
Subscription Agreements
CRISPR Therapeutics AG
Biotechnology
2016